Form 4 Filing for Anterix Inc. - Officer Transaction

Christopher Guttman-McCabe, Chief Regulatory & Commercial Officer of Anterix Inc. (ATEX), reported a transaction on May 20, 2026. The filing indicates the acquisition of 4,926 shares of Common Stock and the grant of 23,271 Stock Options (Right to Buy). The shares were acquired at a price of $0.00, and the stock options have an exercise price of $60.90. Both the shares and options are directly owned. The RSUs vest over three years, with initial vesting on May 20, 2027, and subsequent quarterly vesting until May 20, 2029. Similarly, the stock options vest over three years, with the same vesting schedule. Following these transactions, Mr. Guttman-McCabe directly owns 46,392 shares of Common Stock and holds 23,271 exercisable stock options.